PLUS1
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Genedrive Plc | LSE:GDR | London | Ordinary Share | GB00B1VKB244 | ORD 1.5P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 7.00 | 29.17% | 31.00 | 30.50 | 31.50 | 31.75 | 25.25 | 26.125 | 7,031,425 | 11:57:48 |
| Industry Sector | Turnover (m) | Profit (m) | EPS - Basic | PE Ratio | Market Cap (m) |
|---|---|---|---|---|---|
| Pharmaceuticals & Biotechnology | 0.7 | -1.9 | -1.2 | - | 28 |
Genedrive Shares Rise After Start of FDA Process for MT-RNR1 Product Range
05/10/2022 8:53am
Dow Jones News
Genedrive (LSE:GDR)
Historical Stock Chart
From Jul 2022 to Jan 2023
By Kyle Morris
Shares in Genedrive PLC rose 15% on Wednesday after the company said that it has begun the process for regulatory approval for its MT-RNR1 ID Kit with the U.S. Food and Drug Administration.
The molecular-diagnostics company said the MT-RNR1 assay is a rapid point-of-care test to screen infants in urgent care for a genetic variant that could cause life-long hearing loss when carriers are given certain antibiotics.
Shares in Genedrive at 0721 GMT were up 1.60 pence at 12.60 pence.
Write to Kyle Morris at kyle.morris@dowjones.com
(END) Dow Jones Newswires
October 05, 2022 03:38 ET (07:38 GMT)
Copyright (c) 2022 Dow Jones & Company, Inc.
1 Year Genedrive Chart |
1 Month Genedrive Chart |